header logo image

Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting

April 15th, 2023 12:16 am

Oslo, 14 April 2023: In connection with the Annual General Meeting of Ultimovacs ASA to be held on 20 April 2023, Jónas Einarsson, Chair of the Board of Directors, has so far received proxy based voting rights without voting instructions for 11,364,278 shares, representing 33.04% of the total voting rights in the company.

See the original post:
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick